The Prediction Market for Women's Health & Culture
Sharp questions. Credible resolution. A community that actually knows the domain. Trade on what's next in femtech, fertility, wellness, policy, and culture.
Pre-launch beta. Play money. Real money later pending approvals.
6 markets proposed ยท Every market has a named source
Pre-launch beta with play-money beta credits. Built for clear rules, clean sources, and transparent outcomes.
Market Preview
Real questions. Clear resolution criteria. Odds shown are illustrative โ real trading begins in beta.
Will a major celebrity publicly share a menopause journey that goes viral in 2026?
Resolves: A celebrity's menopause/perimenopause post reaches 1M+ engagements on any platform.
Will a new non-hormonal menopause treatment receive full FDA approval in 2026?
Resolves: FDA grants full approval to a non-hormonal drug specifically for menopause symptoms. Verified via FDA.gov press releases.
Source: FDA.gov
Will women's longevity-focused interventions see a breakthrough funding round exceeding $100M in 2026?
Resolves: A women's longevity startup raises >$100M in a single round, per Crunchbase or similar.
Will microdosing GLP-1 drugs gain widespread use for PCOS management by end of 2026?
Resolves: At least two major health systems or professional organizations recommend GLP-1 for PCOS management.
Will egg freezing costs drop below $8,000 average in the US by end of 2026?
Resolves: Average cost tracked by FertilityIQ or similar authoritative source drops below $8,000.
Will AI-powered at-home diagnostics for endometriosis achieve clinical-grade accuracy in 2026?
Resolves: A peer-reviewed study reports >90% sensitivity and specificity for an AI-based endometriosis diagnostic.
Resolution you can audit
Every market includes a clear resolve-by date, specific criteria that decides yes vs. no, a primary resolution source, and a public record of the outcome. We don't do vibes. We do rules.
Resolve-by date
Every market has a deadline. No open-ended ambiguity.
Yes/No criteria
Specific conditions that decide the outcome. Published before trading opens.
Primary source
FDA.gov, Congress.gov, Crunchbase โ the source is named upfront.
Public record
Resolution decisions are logged with the evidence used. Fully auditable.
How are markets resolved?+
Can anyone change the result?+
Is this real money?+
What we're optimizing for
These are the principles we evaluate every decision against.
Resolution clarity over volume
We'd rather have 20 markets with bulletproof criteria than 200 with vague rules. Every market should be resolvable by a stranger reading the criteria.
Sources you can check
Every market names its resolution source upfront. If the source isn't credible or verifiable, the market doesn't launch.
Domain expertise matters
Clinicians, researchers, patients, and advocates who follow women's health are better forecasters on these questions than the general public.
No fake activity
Zero volume means zero volume. We don't inflate numbers, invent users, or pretend the platform is busier than it is.
Play money first, earn trust
Real-money trading comes only after regulatory approvals and after we've proven the resolution process works. Track records first, stakes second.
Transparency by default
Resolution decisions, criteria changes, and platform updates are public. If we make a mistake, we publish the correction.
Why ForecastHer exists
Prediction markets are powerful because they reward people who see clearly. But most markets ignore the questions women actually care about โ and when they do show up, the resolution rules are often vague.
ForecastHer is building a better standard: markets designed around women's health, femtech, women's sports, culture, and consumer trends, with resolution criteria you can audit.
We're starting with play-money beta credits. Real money comes later, only after the proper approvals. The point right now is simple: build the most credible forecasting community for women-led topics on the internet.
Built with domain expertise
Markets live or die by trust. We care about sources, incentives, and resolution quality.
Product & Markets
People who have built consumer apps and community products at scale.
Women's Health & FemTech
Advisors with experience in women's health, clinical research, and femtech.
Compliance & Operations
Guidance from operators who understand regulatory reality and marketplace integrity.
We're building with the community
Get early access to the beta
Join the waitlist to get beta credits, propose markets, and earn a founding badge.
No spam. Just markets worth arguing about and resolving cleanly.